Home » EV3 PROPOSES TO ACQUIRE PUBLIC MINORITY STAKE IN MICRO THERAPEUTICS
EV3 PROPOSES TO ACQUIRE PUBLIC MINORITY STAKE IN MICRO THERAPEUTICS
ev3, a global endovascular device company, recently announced that it had delivered
a proposal to Micro Therapeutics (MTI) to acquire all of the outstanding shares
of common stock of MTI that ev3 does not already own through an exchange offer.
ev3, through a wholly owned subsidiary, currently owns approximately 70.2 percent
of MTI's common stock.
Yahoo
News
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May